Rivastigmine 24HR Patches
Award Notice Posted
- Solicitation number
- SPE2D221R0113
- Agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Awarded
- to Mylan Pharmaceuticals Inc.
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- SPE2D222D0147 Federal IDV award
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Place of performance
- Saint Albans, Vermont 05478, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Defense Logistics Agency Troop Support Medical awarded a contract for the provision of Rivastigmine 24HR Patches to Mylan Pharmaceuticals Inc. on September 14, 2022. The initial contract value was $10,967,220.00, with subsequent modifications exercising option periods and increasing the unit price to $38.04 during the second option period from September 14, 2024 to September 13, 2025. The contract also includes a clause prohibiting the contractor from providing any covered articles or products/services from sources prohibited under the Federal Acquisition Supply Chain Security Act.
Notice text
4 versions
Update #4 · Latest ·
Modification SPE2D222D0147 P00005 to Invoke Option Year 2 for the period of September 14, 2024 through September 13, 2025.
Modification SPE2D222D0147 P00004 to Invoke THIS CONTRACT IS MODIFIED TO INCLUDE 52.204-30 Federal Acquisition Supply Chain Security Act Orders.
Modification SPE2D222D0147 P00003 to Invoke Option Year 1 for the period of September 14, 2023 through September 13, 2024.
Modification SPE2D222D0147 P00002 to incoporate Drug Supply Chain Security Act (DCSA) into solicitation for subject contract.
Modification SPE2D222D0147 P00001 to incorporate clause FAR 52.204-27 Prohibituion on a Bytedance covered JApplication (June 2023) into subject contract.
Contract Award for Rivastigmine 24HR Patches SPE2D222D0147.
Awarded contract SPE2D222D0147 to Mylan Pharmaceuticals Inc. for 10967220.00 on 2022-09-14.
Update #3 ·
Modification SPE2D222D0147 P00003 to Invoke Option Year 1 for the period of September 14, 2023 through September 13, 2024.
Modification SPE2D222D0147 P00002 to incoporate Drug Supply Chain Security Act (DCSA) into solicitation for subject contract.
Modification SPE2D222D0147 P00001 to incorporate clause FAR 52.204-27 Prohibituion on a Bytedance covered JApplication (June 2023) into subject contract.
Contract Award for Rivastigmine 24HR Patches SPE2D222D0147.
Awarded contract SPE2D222D0147 to Mylan Pharmaceuticals Inc. for 10967220.00 on 2022-09-14.
Update #2 ·
Modification SPE2D222D0147 P00002 to incoporate Drug Supply Chain Security Act (DCSA) into solicitation for subject contract.
Modification SPE2D222D0147 P00001 to incorporate clause FAR 52.204-27 Prohibituion on a Bytedance covered JApplication (June 2023) into subject contract.
Contract Award for Rivastigmine 24HR Patches SPE2D222D0147.
Awarded contract SPE2D222D0147 to Mylan Pharmaceuticals Inc. for 10967220.00 on 2022-09-14.
Update #1 ·
Contract Award for Rivastigmine 24HR Patches SPE2D222D0147.
Awarded contract SPE2D222D0147 to Mylan Pharmaceuticals Inc. for 10967220.00 on 2022-09-14.
Files
Notice history
| Notice | Type | Posted |
|---|---|---|
| This notice | Award Notice | |
| Rivastigmine 24HR Patches | Solicitation | |
| Rivastigmine 24HR Patches | Pre-Solicitation |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity